Rigel Pharmaceuticals Inc (RIGL)

Other Income/Expenses (Net)

-$1.47M

TTM · Period ending: · USD

RIGL logo

RIGL Other Income/Expenses (Net)

Latest reported-$1.47M
RIGL Other Income/Expenses (Net) ($0.00 → -$1.47M)
High-resolution chart · PNG

RIGL other income/expenses (net) history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Rigel Pharmaceuticals Inc Other Income/Expenses (Net) — Annual fiscal periods (USD)
Period endingOther Income/Expenses (Net) (USD)
-3,639,000
-5,826,000
-4,600,000
-3,023,000
-4,813,000
-771,000
2,197,000
2,203,000
1,624,000
525,000
279,000
341,000
442,000
537,000
395,000
2,573,000
397,000
4,279,000
5,255,000
5,410,000
2,666,000
612,000
-370,000
-14,000
1,155,000
145,000
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.